“Overview of the advantages and disadvantages of chimeric antigen receptor T cell therapy in the tumor microenvironment”, Biomed. Res. Ther., vol. 9, no. 10, pp. 5341–5350, Oct. 2022, doi: 10.15419/bmrat.v9i10.772.